CLINICAL_TRIALS
trial_result
· 2020-02-25
Clinical Trial Update: Randomized Controlled Trial for Exparel Hip Fracture [Phase 4]
Summary
A Phase 4 randomized controlled trial evaluating Exparel for hip fracture has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Massachusetts, Worcester | Conditions: Hip Fractures | Phase 4 | Status: COMPLETED | Results posted: 2020-02-25